Nouvelles

Teva Canada Appoints Michael Sine as General Manager

lundi, 11 juillet 2022

Teva Canada Appoints Michael Sine as NEW General Manager.
Read the Full Release 

2D Barcoding: One Year Later

mardi, 8 mars 2022

2D Barcoding: One Year Later on April 7, 1:00 - 2:00 PM EST
This free webinar will cover lessons learned and activities since CAPDM’s first webinar on 2D barcoding one year ago, and needs arising from our February implementation barriers workshops.

CAPDM Welcomes Paladin Labs Inc.

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Paladin Labs Inc. With headquarters in Montréal, Canada, Paladin Labs Inc. is a leading specialty pharmaceutical company focused on acquiring or licensing emerging pharmaceuticals for the Canadian market.
 
Their dedicated sales and marketing organization has propelled Paladin to become one of Canada’s pioneers in specialty pharmaceuticals.
 

JAMP and Alvotech Announce Canadian Approval of SIMLANDI™

jeudi, 20 janvier 2022

January 20, 2022
JAMP and Alvotech Announce Canadian Approval of SIMLANDI™, a High-Concentration Biosimilar to Humira®, Providing Access  to Previously Unavailable Versions in Canada 

Read the Full Release

CAPDM Welcomes Aspen Canada Inc.

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Aspen Canada Inc. Headquartered in Durban, South Africa, with offices in Oakville , Ontario , Aspen is a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines. 

CAPDM Welcomes Fresenius Kabi Canada

jeudi, 20 janvier 2022

CAPDM Welcomes New Member Fresenius Kabi Canada, specializes in lifesaving medicines and technologies for infusion, transfusion and parenteral nutrition. 
  

CAPDM Welcomes Organon

mardi, 14 décembre 2021

CAPDM Welcomes New Member Organon. Organon is the largest pharma company of its size dedicated to women’s health. 

CAPDM welcomes Sentrex Health Solutions

mercredi, 8 décembre 2021

CAPDM welcomes new member Sentrex Health Solutions. Utilizing strategic distribution models and patient support programs backed by powerful, integrated technology and experienced cross-functional teams, Sentrex provides innovative solutions focused on ensuring patients have the access and support they need to optimize their treatment outcomes.


  

2D Barcoding: Your Questions Answered

lundi, 4 octobre 2021

November 4, 2021 at 1:00 to 2:30 pm ET

Hosted by CAPDM and featuring GS1 Canada, this free webinar will answer the top member question arising from CAPDM’s August 2D Barcoding survey. 

Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide

mercredi, 1 septembre 2021

September 1, 2021
Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market.

Read the Full Release